An architecture for COVID-19 analysis and detection using big data, AI, and data architectures.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2024
Historique:
received: 16 12 2023
accepted: 31 05 2024
medline: 1 8 2024
pubmed: 1 8 2024
entrez: 1 8 2024
Statut: epublish

Résumé

The COVID-19 epidemic is affecting individuals in many ways and continues to spread all over the world. Vaccines and traditional medical techniques are still being researched. In diagnosis and therapy, biological and digital technology is used to overcome the fear of this disease. Despite recovery in many patients, COVID-19 does not have a definite cure or a vaccine that provides permanent protection for a large number of people. Current methods focus on prevention, monitoring, and management of the spread of the disease. As a result, new technologies for combating COVID-19 are being developed. Though unreliable due to a lack of sufficient COVID-19 datasets, inconsistencies in the datasets availability, non-aggregation of the database because of conflicting data formats, incomplete information, and distortion, they are a step in the right direction. Furthermore, the privacy and confidentiality of people's medical data are only partially ensured. As a result, this research study proposes a novel, cooperative approach that combines big data analytics with relevant Artificial Intelligence (AI) techniques and blockchain to create a system for analyzing and detecting COVID-19 instances. Based on these technologies, the reliability, affordability, and prominence of dealing with the above problems required time. The architecture of the proposed model will analyze different data sources for preliminary diagnosis, detect the affected area, and localize the abnormalities. Furthermore, the blockchain approach supports the decentralization of the central repository so that it is accessible to every stakeholder. The model proposed in this study describes the four-layered architecture. The purpose of the proposed architecture is to utilize the latest technologies to provide a reliable solution during the pandemic; the proposed architecture was sufficient to cover all the current issues, including data security. The layers are unique and individually responsible for handling steps required for data acquisition, storage, analysis, and reporting using blockchain principles in a decentralized P2P network. A systematic review of the technologies to use in the pandemic covers all possible solutions that can cover the issue best and provide a secure solution to the pandemic.

Identifiants

pubmed: 39088543
doi: 10.1371/journal.pone.0305483
pii: PONE-D-23-42372
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0305483

Informations de copyright

Copyright: © 2024 Alghamdi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Ahmed Mohammed Alghamdi (AM)

Department of Software Engineering, College of Computer Science and Engineering, University of Jeddah, Jeddah, Saudi Arabia.

Waleed A Al Shehri (WA)

Department of Computing, College of Engineering and Computing in Al-Lith, Umm Al-Qura University, Makkah, Saudi Arabia.

Jameel Almalki (J)

Department of Computing, College of Engineering and Computing in Al-Lith, Umm Al-Qura University, Makkah, Saudi Arabia.

Najlaa Jannah (N)

Department of Computing, College of Engineering and Computing in Al-Lith, Umm Al-Qura University, Makkah, Saudi Arabia.

Faisal S Alsubaei (FS)

Department of Cybersecurity, College of Computer Science and Engineering, University of Jeddah, Jeddah, Saudi Arabia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH